首页 > 最新文献

Research in Cardiovascular Medicine最新文献

英文 中文
Focal right ventricular apical hypertrophy or apical muscular ventricular septal defect 局灶性右心室心尖肥厚或心尖肌性室间隔缺损
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2020-07-01 DOI: 10.4103/rcm.rcm_35_20
Z. Sani, Taimoor Etemad, M. Behjati, Z. Khajali, R. Alizadehsani, A. Khosravi, S. Nahavandi, S. S. Shariful Islam
A 28-year-old male patient was referred to our imaging center with the differential diagnosis of a right ventricular (RV) apical mass. He was a known case of the ventricular septal defect (VSD) with a history of spontaneous closure at the age of 2 years. His chief complaint was chest pain and palpitation. He was referred with a transthoracic echocardiography report of RV apical hypertrophy with almost apical obliteration or RV apical mass. Cardiovascular magnetic resonance imaging demonstrated few intramyocardial crypts of basal anteroseptal left ventricular (LV) segment. There was no evidence of concomitant LV apical hypertrophy. Indeed, there was a small conical- and tunnel-shaped serpiginous apical-infundibular muscular VSD (3.6 mm RV side's diameter and 7.6 mm LV side's diameter) resulted in a localized and severely hypertrophied RV apical segment and no significant shunt (QP/QS: 1.16). There was no evidence of other cardiac mass.
一名28岁的男性患者被转诊到我们的影像中心,对右心室(RV)心尖肿块进行鉴别诊断。他是一名已知的室间隔缺损(VSD)病例,2岁时有自发闭合史。他的主要症状是胸痛和心悸。他被转诊为右心室心尖肥大伴几乎心尖闭塞或左心室心尖肿块的经胸超声心动图报告。心血管磁共振成像显示基底前间隔左心室(LV)段很少有心肌内隐窝。没有证据表明伴随左心室心尖肥大。事实上,有一个小的圆锥形和隧道状的螺旋状顶端漏斗肌VSD(右心室侧直径3.6 mm,左心室侧直径7.6 mm)导致右心室心尖段局部严重肥大,没有明显分流(QP/QS:1.16)。没有其他心脏肿块的证据。
{"title":"Focal right ventricular apical hypertrophy or apical muscular ventricular septal defect","authors":"Z. Sani, Taimoor Etemad, M. Behjati, Z. Khajali, R. Alizadehsani, A. Khosravi, S. Nahavandi, S. S. Shariful Islam","doi":"10.4103/rcm.rcm_35_20","DOIUrl":"https://doi.org/10.4103/rcm.rcm_35_20","url":null,"abstract":"A 28-year-old male patient was referred to our imaging center with the differential diagnosis of a right ventricular (RV) apical mass. He was a known case of the ventricular septal defect (VSD) with a history of spontaneous closure at the age of 2 years. His chief complaint was chest pain and palpitation. He was referred with a transthoracic echocardiography report of RV apical hypertrophy with almost apical obliteration or RV apical mass. Cardiovascular magnetic resonance imaging demonstrated few intramyocardial crypts of basal anteroseptal left ventricular (LV) segment. There was no evidence of concomitant LV apical hypertrophy. Indeed, there was a small conical- and tunnel-shaped serpiginous apical-infundibular muscular VSD (3.6 mm RV side's diameter and 7.6 mm LV side's diameter) resulted in a localized and severely hypertrophied RV apical segment and no significant shunt (QP/QS: 1.16). There was no evidence of other cardiac mass.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"9 1","pages":"75 - 76"},"PeriodicalIF":0.3,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43235717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical profile and angiographic patterns of patients undergoing treatment for in-stent restenosis and outcomes associated with the treatment 接受支架内再狭窄治疗的患者的临床特征和血管造影模式以及与治疗相关的结果
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2020-07-01 DOI: 10.4103/rcm.rcm_21_20
S. Patil, M. Chatterjee, Natraj Setty, S. Jadhav
Context: The optimal treatment strategy for in-stent restenosis (ISR) still remains under debate. Moreover, there have been scarce data on Indian patients relating to ISR treatment. Aim: The aim of this study was to determine the clinical profile and angiographic pattern of patients with ISR and to evaluate the outcome of these patients being treated for ISR. Settings and Design: This was a cross-sectional study which consisted of patients who had coronary angiographic characteristic of ISR. Materials and Methods: Patients were divided into subgroups as per presentation, acute coronary syndrome (ACS), and non-ACS. After the ISR event and treatment, the patients were followed up for a minimum period of 6 months for any adverse events. The primary outcome of the study was occurrence of a major adverse cardiac event. Statistical Analysis: Chi-square test, Fisher's exact test, Student's t-test, or Mann–Whitney test was applied according to type and distribution of variable (SPSS software). Results: One hundred patients with 109 culprit lesions of ISR were included in the study. The ACS was dominant clinical presentation mode, occurring in 62 patients. Fifty-four percent of the patients were treated with percutaneous coronary intervention, 26% were managed with coronary artery bypass grafting, and 19% were treated with optimized medical therapy. Majority of the adverse events (12 out of 15 patients) occurred in the ACS group, with a statistically significant difference at 6-month follow-up (P = 0.021). Conclusion: Patients with ISR have ACS as the most common mode of presentation. Patients with ISR presenting with ACS are at high risk and must be closely monitored. The treatment of ISR with drug-eluting stent or drug-coated balloon is most effective.
背景:支架内再狭窄(ISR)的最佳治疗策略仍存在争议。此外,印度患者与ISR治疗相关的数据很少。目的:本研究的目的是确定ISR患者的临床特征和血管造影模式,并评估这些患者接受ISR治疗的结果。背景和设计:这是一项横断面研究,由具有ISR冠状动脉造影特征的患者组成。材料和方法:将患者按表现分为急性冠脉综合征(ACS)和非ACS亚组。在ISR事件和治疗后,对患者进行至少6个月的随访,以了解任何不良事件。该研究的主要结局是主要心脏不良事件的发生。统计分析:根据变量的类型和分布,采用卡方检验、Fisher确切检验、Student’st检验或Mann-Whitney检验(SPSS软件)。结果:纳入100例ISR罪魁祸首病变109例。ACS为主要临床表现模式,共62例。54%的患者行经皮冠状动脉介入治疗,26%行冠状动脉旁路移植术,19%行优化药物治疗。ACS组不良事件发生率最高(15例患者中有12例),6个月随访差异有统计学意义(P = 0.021)。结论:ISR患者以ACS为主要表现形式。伴有ACS的ISR患者处于高风险,必须密切监测。药物洗脱支架或药物包被球囊治疗ISR最有效。
{"title":"Clinical profile and angiographic patterns of patients undergoing treatment for in-stent restenosis and outcomes associated with the treatment","authors":"S. Patil, M. Chatterjee, Natraj Setty, S. Jadhav","doi":"10.4103/rcm.rcm_21_20","DOIUrl":"https://doi.org/10.4103/rcm.rcm_21_20","url":null,"abstract":"Context: The optimal treatment strategy for in-stent restenosis (ISR) still remains under debate. Moreover, there have been scarce data on Indian patients relating to ISR treatment. Aim: The aim of this study was to determine the clinical profile and angiographic pattern of patients with ISR and to evaluate the outcome of these patients being treated for ISR. Settings and Design: This was a cross-sectional study which consisted of patients who had coronary angiographic characteristic of ISR. Materials and Methods: Patients were divided into subgroups as per presentation, acute coronary syndrome (ACS), and non-ACS. After the ISR event and treatment, the patients were followed up for a minimum period of 6 months for any adverse events. The primary outcome of the study was occurrence of a major adverse cardiac event. Statistical Analysis: Chi-square test, Fisher's exact test, Student's t-test, or Mann–Whitney test was applied according to type and distribution of variable (SPSS software). Results: One hundred patients with 109 culprit lesions of ISR were included in the study. The ACS was dominant clinical presentation mode, occurring in 62 patients. Fifty-four percent of the patients were treated with percutaneous coronary intervention, 26% were managed with coronary artery bypass grafting, and 19% were treated with optimized medical therapy. Majority of the adverse events (12 out of 15 patients) occurred in the ACS group, with a statistically significant difference at 6-month follow-up (P = 0.021). Conclusion: Patients with ISR have ACS as the most common mode of presentation. Patients with ISR presenting with ACS are at high risk and must be closely monitored. The treatment of ISR with drug-eluting stent or drug-coated balloon is most effective.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"9 1","pages":"55 - 60"},"PeriodicalIF":0.3,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42055770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic modality of the long QT syndrome: Lesson from the past 长QT综合征的治疗方式:从过去的经验教训
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2020-07-01 DOI: 10.4103/rcm.rcm_30_20
E. Begić, E. Hodžić, Z. Begić, A. Iglica, N. Begić, Omer Jusic
Long QT syndrome (LQTS) is a rare (1:2500–1:10,000) inherited disorder characterized by the onset of arrhythmogenic syncope, polymorphic ventricular tachycardia, and sudden cardiac death. The aim of this article was to describe an unexpected success with an unusual therapeutic modality of a patient diagnosed with LQTS syndrome (suspected Romano–Ward syndrome) during an 8-year period. A 59-year-old female patient was admitted to the hospital due to chest pain and nausea, and after diagnostic and therapeutical approach, a permanent dual-chamber rate-modulated (DDDR) pacemaker was implanted instead of the implantable cardioverter defibrillator (ICD). During the 8-year period, the patient remained stable, without rhythm disorder. Romano–Ward syndrome as a congenital LQTS carries a high risk of sudden cardiac death and presents an indication for ICD. In this patient, for objective reasons, this could not be performed. Implantation of a DDDR with an appropriate pharmacological therapy, including propranolol, in this case, proved to be a successful therapeutic modality.
长QT综合征(LQTS)是一种罕见的(1:2500 - 1:10 000)遗传性疾病,以心律失常性晕厥、多形性室性心动过速和心源性猝死为特征。本文的目的是描述在8年期间诊断为LQTS综合征(疑似罗曼诺-沃德综合征)的患者的一种不同寻常的治疗方式的意外成功。一名59岁女性患者因胸痛和恶心入院,经过诊断和治疗,植入永久性双室调频(DDDR)起搏器代替植入式心律转复除颤器(ICD)。8年期间,患者病情稳定,无节律障碍。Romano-Ward综合征是一种先天性LQTS,具有较高的心源性猝死风险,是ICD的适应症。在本例患者中,由于客观原因,不能进行这种手术。在这种情况下,植入DDDR和适当的药物治疗,包括心得安,被证明是一种成功的治疗方式。
{"title":"Therapeutic modality of the long QT syndrome: Lesson from the past","authors":"E. Begić, E. Hodžić, Z. Begić, A. Iglica, N. Begić, Omer Jusic","doi":"10.4103/rcm.rcm_30_20","DOIUrl":"https://doi.org/10.4103/rcm.rcm_30_20","url":null,"abstract":"Long QT syndrome (LQTS) is a rare (1:2500–1:10,000) inherited disorder characterized by the onset of arrhythmogenic syncope, polymorphic ventricular tachycardia, and sudden cardiac death. The aim of this article was to describe an unexpected success with an unusual therapeutic modality of a patient diagnosed with LQTS syndrome (suspected Romano–Ward syndrome) during an 8-year period. A 59-year-old female patient was admitted to the hospital due to chest pain and nausea, and after diagnostic and therapeutical approach, a permanent dual-chamber rate-modulated (DDDR) pacemaker was implanted instead of the implantable cardioverter defibrillator (ICD). During the 8-year period, the patient remained stable, without rhythm disorder. Romano–Ward syndrome as a congenital LQTS carries a high risk of sudden cardiac death and presents an indication for ICD. In this patient, for objective reasons, this could not be performed. Implantation of a DDDR with an appropriate pharmacological therapy, including propranolol, in this case, proved to be a successful therapeutic modality.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"9 1","pages":"72 - 74"},"PeriodicalIF":0.3,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44729959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Importance of great cardiac vein signal in the differentiation of premature ventricular contraction origins in right and left ventricular outflow tracts 大心静脉信号在区分左心室流出道和右心室早搏起源中的重要性
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2020-07-01 DOI: 10.4103/rcm.rcm_23_20
A. Fazelifar, Behzad Amanpour, M. Heidarali, A. Arani
Background and Aim: “Idiopathic” ventricular arrhythmias most often arise from the right ventricular outflow tract (RVOT), although arrhythmias from the left ventricular outflow tract (LVOT) have also been observed. The aim of the study was to investigate the importance of signal of great cardiac vein (GCV) to distinguish premature ventricular contraction (PVC) originated from LVOT and PVC originated from RVOT. Materials and Methods: A coronary sinus catheter was placed in the GCV under fluoroscopy to measure the distance of GCV signal to the onset of QRS on surface electrocardiogram (ECG). Catheter ablation was performed utilizing radiofrequency energy in 31 patients. A 12-lead ECG was recorded during PVC. Successful ablation was defined as the complete disappearance of target PVC with no recurrence during the follow-up. Results: Thirty-one consecutive patients (16 male [51.6%]) were enrolled. Overall, 67.7% of the cases had PVC originated from the LVOT and 32.3% from the RVOT. Out of 48.4% of the females, 33.3% had PVC originated from the RVOT and 66.7% from the LVOT (P = 1). The mean ejection fraction regarding PVC originated from the LVOT and RVOT was 47.50 ± 8.95 and 45.50 ± 8.51, respectively (P = 0.7). The distance of GCV signal to the onset of QRS on surface ECG for LVOT- and RVOT-originated PVC was 15.38 ± 25.28 and −29.70 ± 25.66, respectively (P < 0.01). Conclusions: The differentiation between PVC originated from LVOT and RVOT is not entirely utilized through ECG criteria, thus the origin of PVC arising from RVOT/LVOT can be localized using the GCV signals.
背景和目的:“特发性”室性心律失常最常见于右心室流出道(RVOT),尽管也观察到来自左心室流出道的心律失常。本研究的目的是探讨心大静脉信号(GCV)在区分起源于LVOT的室性早搏(PVC)和起源于RVOT的PVC中的重要性。材料和方法:在荧光镜下将冠状窦导管置于GCV中,在表面心电图(ECG)上测量GCV信号到QRS发作的距离。利用射频能量对31名患者进行导管消融术。PVC过程中记录了12导联心电图。成功的消融被定义为在随访期间目标PVC完全消失且无复发。结果:31名连续患者(16名男性[51.6%])入选。总体而言,67.7%的病例的PVC来源于左心室流出道,32.3%来源于右心室流出道。48.4%的女性中,33.3%的PVC来源于右心室流出道,66.7%来源于左心室流出道(P=1)。起源于LVOT和RVOT的PVC的平均射血分数分别为47.50±8.95和45.50±8.51(P=0.07),结论:LVOT引起的PVC与RVOT之间的鉴别不能完全通过心电图来判断,因此可以通过GCV信号来定位RVOT/LVOT引起的PVC的起源。
{"title":"Importance of great cardiac vein signal in the differentiation of premature ventricular contraction origins in right and left ventricular outflow tracts","authors":"A. Fazelifar, Behzad Amanpour, M. Heidarali, A. Arani","doi":"10.4103/rcm.rcm_23_20","DOIUrl":"https://doi.org/10.4103/rcm.rcm_23_20","url":null,"abstract":"Background and Aim: “Idiopathic” ventricular arrhythmias most often arise from the right ventricular outflow tract (RVOT), although arrhythmias from the left ventricular outflow tract (LVOT) have also been observed. The aim of the study was to investigate the importance of signal of great cardiac vein (GCV) to distinguish premature ventricular contraction (PVC) originated from LVOT and PVC originated from RVOT. Materials and Methods: A coronary sinus catheter was placed in the GCV under fluoroscopy to measure the distance of GCV signal to the onset of QRS on surface electrocardiogram (ECG). Catheter ablation was performed utilizing radiofrequency energy in 31 patients. A 12-lead ECG was recorded during PVC. Successful ablation was defined as the complete disappearance of target PVC with no recurrence during the follow-up. Results: Thirty-one consecutive patients (16 male [51.6%]) were enrolled. Overall, 67.7% of the cases had PVC originated from the LVOT and 32.3% from the RVOT. Out of 48.4% of the females, 33.3% had PVC originated from the RVOT and 66.7% from the LVOT (P = 1). The mean ejection fraction regarding PVC originated from the LVOT and RVOT was 47.50 ± 8.95 and 45.50 ± 8.51, respectively (P = 0.7). The distance of GCV signal to the onset of QRS on surface ECG for LVOT- and RVOT-originated PVC was 15.38 ± 25.28 and −29.70 ± 25.66, respectively (P < 0.01). Conclusions: The differentiation between PVC originated from LVOT and RVOT is not entirely utilized through ECG criteria, thus the origin of PVC arising from RVOT/LVOT can be localized using the GCV signals.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"9 1","pages":"61 - 64"},"PeriodicalIF":0.3,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44245652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of continuous holter of blood pressure in pediatric population: Single-center experience and review of literature 在儿科人群中使用连续动态血压仪:单中心经验和文献回顾
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2020-07-01 DOI: 10.4103/rcm.rcm_31_20
Z. Begić, N. Begić, E. Begić, D. Šečić, S. Begić
Introduction: A Holter blood pressure monitoring is a basic method for the diagnosis and evaluation of hypertension therapy. Hypertension in children and adolescents is defined as an increase of systolic/diastolic pressure, which is equal, or above 95th percentile blood pressure for sex, age, and height. Aim: The aim of this study is to analyze the etiology of arterial hypertension (AH) in the pediatric population. Methods: Research had descriptive and retrospective character. During the period from March 2006 to April 2020, 1527 registered continuous Holters of blood pressure were analyzed. Data were taken from the medical documentation of patients that were hospitalized on Pediatric Clinic (register of continuous Holter of blood pressure). Results: Out of the total number of registered and analyzed patients 833 were male (54.5%) with dominant age 15–19 years of life 774 (50.6%), school-age children 660 (43.2%), preschool children 93 (6.1%). We had 902 (59%) first registrations and 626 (41%) control registrations. AH was verified in 52 patients (387 records of continuous Holter of blood pressure were performed to them). Primary AH was verified in 27 patients and secondary AH in 25 patients. Forty patients (76.9%) were treated with monotherapy while combined therapy was used in 12 (23.1%) of cases. Renal cause was in 28% patients, endocrine in 24%, cardiovascular in 24%, neurological in 16%, and rheumatic in 8% of patients with secondary AH. Conclusion: Continuous Holter of blood pressure represents useful diagnostic method and method of control of high blood pressure in children and adolescents. It should be routine method in everyday pediatric clinical practice especially in pediatric cardiology.
引言:动态心电图血压监测是诊断和评价高血压治疗的基本方法。儿童和青少年的高血压被定义为收缩压/舒张压升高,对于性别、年龄和身高而言,收缩压等于或高于第95百分位的血压。目的:本研究的目的是分析儿科人群中动脉高压(AH)的病因。方法:研究具有描述性和回顾性。在2006年3月至2020年4月期间,对1527例登记的连续动态心电图血压进行了分析。数据取自儿科诊所住院患者的医疗文件(连续动态心电图血压记录)。结果:在登记和分析的患者总数中,833人为男性(54.5%),主要年龄为15-19岁,774人(50.6%),学龄儿童660人(43.2%),学龄前儿童93人(6.1%)。我们有902人(59%)首次登记,626人(41%)对照登记。在52名患者中验证了AH(对他们进行了387次连续动态心电图血压记录)。原发性AH在27例患者中得到证实,继发性AH在25例患者中获得证实。单药治疗40例(76.9%),联合治疗12例(23.1%)。28%的继发性AH患者为肾脏原因,24%为内分泌原因,24%是心血管原因,16%是神经原因,8%是风湿性原因。结论:连续动态心电图是诊断儿童青少年高血压的有效方法和控制方法。它应该是日常儿科临床实践中的常规方法,尤其是在儿科心脏病学中。
{"title":"Use of continuous holter of blood pressure in pediatric population: Single-center experience and review of literature","authors":"Z. Begić, N. Begić, E. Begić, D. Šečić, S. Begić","doi":"10.4103/rcm.rcm_31_20","DOIUrl":"https://doi.org/10.4103/rcm.rcm_31_20","url":null,"abstract":"Introduction: A Holter blood pressure monitoring is a basic method for the diagnosis and evaluation of hypertension therapy. Hypertension in children and adolescents is defined as an increase of systolic/diastolic pressure, which is equal, or above 95th percentile blood pressure for sex, age, and height. Aim: The aim of this study is to analyze the etiology of arterial hypertension (AH) in the pediatric population. Methods: Research had descriptive and retrospective character. During the period from March 2006 to April 2020, 1527 registered continuous Holters of blood pressure were analyzed. Data were taken from the medical documentation of patients that were hospitalized on Pediatric Clinic (register of continuous Holter of blood pressure). Results: Out of the total number of registered and analyzed patients 833 were male (54.5%) with dominant age 15–19 years of life 774 (50.6%), school-age children 660 (43.2%), preschool children 93 (6.1%). We had 902 (59%) first registrations and 626 (41%) control registrations. AH was verified in 52 patients (387 records of continuous Holter of blood pressure were performed to them). Primary AH was verified in 27 patients and secondary AH in 25 patients. Forty patients (76.9%) were treated with monotherapy while combined therapy was used in 12 (23.1%) of cases. Renal cause was in 28% patients, endocrine in 24%, cardiovascular in 24%, neurological in 16%, and rheumatic in 8% of patients with secondary AH. Conclusion: Continuous Holter of blood pressure represents useful diagnostic method and method of control of high blood pressure in children and adolescents. It should be routine method in everyday pediatric clinical practice especially in pediatric cardiology.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"9 1","pages":"65 - 71"},"PeriodicalIF":0.3,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41380819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful pulmonary artery balloon angioplasty in a rare case of arterial tortuosity syndrome 一例罕见动脉迂曲综合征肺动脉球囊成形术成功
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2020-04-01 DOI: 10.4103/rcm.rcm_16_20
Maryam Aliramezany, A. Firouzi, M. Parsaee, Z. Khajali
Arterial tortuosity syndrome (ATS) is a very rare autosomal recessive disease which results from mutations of the SLC2A10 gene. In this article, we describe the results of vascular imaging of an adult patient with ATS who was presented with pulmonary hypertension and after a complete evaluation, he was a candidate for interventional balloon angioplasty. Our patient is one of the very limited numbers of list patients in the studies for whom percutaneous balloon angioplasty performed successfully.
动脉扭曲综合征(ATS)是由SLC2A10基因突变引起的一种非常罕见的常染色体隐性遗传病。在这篇文章中,我们描述了一名成年ATS患者的血管成像结果,该患者表现为肺动脉高压,经过全面评估后,他是介入球囊血管成形术的候选人。我们的患者是研究中为数不多的经皮球囊血管成形术成功的患者之一。
{"title":"Successful pulmonary artery balloon angioplasty in a rare case of arterial tortuosity syndrome","authors":"Maryam Aliramezany, A. Firouzi, M. Parsaee, Z. Khajali","doi":"10.4103/rcm.rcm_16_20","DOIUrl":"https://doi.org/10.4103/rcm.rcm_16_20","url":null,"abstract":"Arterial tortuosity syndrome (ATS) is a very rare autosomal recessive disease which results from mutations of the SLC2A10 gene. In this article, we describe the results of vascular imaging of an adult patient with ATS who was presented with pulmonary hypertension and after a complete evaluation, he was a candidate for interventional balloon angioplasty. Our patient is one of the very limited numbers of list patients in the studies for whom percutaneous balloon angioplasty performed successfully.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"9 1","pages":"52 - 54"},"PeriodicalIF":0.3,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46729985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Rajaie cardiovascular medical and research center-percutaneous coronary intervention registry: A real-world registry on coronary interventions in a tertiary teaching cardiovascular center Rajaie心血管医学和研究中心经皮冠状动脉介入治疗注册:三级心血管教学中心冠状动脉介入的真实注册
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2020-04-01 DOI: 10.4103/rcm.rcm_11_20
H. Basiri, E. Khalilipur, A. Sarreshtedari, R. Zolfaghari, Parham Sadeghipour, M. Alemzadeh-Ansari, B. Mohebbi, A. Rashidinejad, Zahra Hosseini, Ali Zahedmedhr, A. Firouzi, F. Noohi, M. Kiavar, M. Peighambari, S. Abdi, Mohsen Maadani, Farshad Shakerian, R. Kiani, A. Mohebbi, M. Momtahen, M. Sadrameli, H. Sanati, O. Shafe, J. Moosavi, Yousef Moghadam, Reza Golpira, M. Maleki
Introduction: Clinical registries are a targeted way of data collection aimed at finding a solution to a specific clinical inquiry. The present report introduces the Rajaie Cardiovascular, Medical and Research Center percutaneous coronary intervention (RHC-PCI) Registry. The primary objectives of the RHC-PCI Registry consist of monitoring different complex PCI procedures and their mutual impact on interventional cardiology programs. Methods: RHC is a large and well-known cardiovascular tertiary center in Iran. The RHC-PCI Registry was first launched in 2015, since which time it has collected >5000 parameters regarding the baseline, clinical, and procedural characteristics of various PCI procedures. Noncomplex coronary interventions, bifurcation stenting, left main interventions, chronic total occlusion (CTO) PCI, and bypass graft interventions comprise the major categories gathered by the RHC-PCI Registry. The main registry outcomes are comprised in-hospital mortality, major adverse cardiovascular events, vascular access site complications, and 6-month all-cause mortality. Results: In this primary report, we elaborate on the principal infrastructure of the RHC-PCI Registry and present a synopsis of the registry scope. During the first 40 months of the registry, 11,005 patients underwent PCI. The acute coronary syndrome was reported in 5043 (45.8%) patients. Bifurcation stenting, left main interventions, CTO PCI, and bypass graft interventions were performed in 1679 (15.2%), 236 (2.1%), 946 (8.5%), and 764 (6.9%) patients, respectively. The preferred access site was the femoral artery (n = 6614, 60%), and drug-eluting stents were deployed in 9230 (83.8%) patients. In-hospital mortality in the total registry data was reported in 104 (0.9%) patients. Conclusions: This report introduces the RHC-PCI Registry, its primary objectives, infrastructure, and preliminary results (the 3-year outcome).
引言:临床登记是一种有针对性的数据收集方式,旨在为特定的临床调查找到解决方案。本报告介绍了Rajaie心血管、医学和研究中心经皮冠状动脉介入治疗(RHC-PCI)注册中心。RHC-PCI注册的主要目标包括监测不同的复杂PCI程序及其对介入心脏病学项目的相互影响。方法:RHC是伊朗著名的大型心血管三级中心。RHC-PCI注册中心于2015年首次启动,从那时起,它已经收集了超过5000个关于各种PCI手术的基线、临床和程序特征的参数。非复杂冠状动脉介入治疗、分叉支架置入术、左主干介入治疗、慢性完全闭塞(CTO)PCI和旁路移植介入治疗是RHC-PCI注册中心收集的主要类别。主要登记结果包括住院死亡率、主要心血管不良事件、血管通路部位并发症和6个月全因死亡率。结果:在本主要报告中,我们详细介绍了RHC-PCI注册中心的主要基础设施,并简要介绍了注册中心的范围。在注册的前40个月,11005名患者接受了PCI。5043例(45.8%)患者报告了急性冠状动脉综合征。分别对1679名(15.2%)、236名(2.1%)、946名(8.5%)和764名(6.9%)患者进行了分叉支架置入术、左主干介入术、CTO PCI和搭桥术。首选进入部位为股动脉(n=6614,60%),9230名(83.8%)患者使用了药物洗脱支架。104名(0.9%)患者报告了总登记数据中的住院死亡率。结论:本报告介绍了RHC-PCI注册、主要目标、基础设施和初步结果(3年结果)。
{"title":"Rajaie cardiovascular medical and research center-percutaneous coronary intervention registry: A real-world registry on coronary interventions in a tertiary teaching cardiovascular center","authors":"H. Basiri, E. Khalilipur, A. Sarreshtedari, R. Zolfaghari, Parham Sadeghipour, M. Alemzadeh-Ansari, B. Mohebbi, A. Rashidinejad, Zahra Hosseini, Ali Zahedmedhr, A. Firouzi, F. Noohi, M. Kiavar, M. Peighambari, S. Abdi, Mohsen Maadani, Farshad Shakerian, R. Kiani, A. Mohebbi, M. Momtahen, M. Sadrameli, H. Sanati, O. Shafe, J. Moosavi, Yousef Moghadam, Reza Golpira, M. Maleki","doi":"10.4103/rcm.rcm_11_20","DOIUrl":"https://doi.org/10.4103/rcm.rcm_11_20","url":null,"abstract":"Introduction: Clinical registries are a targeted way of data collection aimed at finding a solution to a specific clinical inquiry. The present report introduces the Rajaie Cardiovascular, Medical and Research Center percutaneous coronary intervention (RHC-PCI) Registry. The primary objectives of the RHC-PCI Registry consist of monitoring different complex PCI procedures and their mutual impact on interventional cardiology programs. Methods: RHC is a large and well-known cardiovascular tertiary center in Iran. The RHC-PCI Registry was first launched in 2015, since which time it has collected >5000 parameters regarding the baseline, clinical, and procedural characteristics of various PCI procedures. Noncomplex coronary interventions, bifurcation stenting, left main interventions, chronic total occlusion (CTO) PCI, and bypass graft interventions comprise the major categories gathered by the RHC-PCI Registry. The main registry outcomes are comprised in-hospital mortality, major adverse cardiovascular events, vascular access site complications, and 6-month all-cause mortality. Results: In this primary report, we elaborate on the principal infrastructure of the RHC-PCI Registry and present a synopsis of the registry scope. During the first 40 months of the registry, 11,005 patients underwent PCI. The acute coronary syndrome was reported in 5043 (45.8%) patients. Bifurcation stenting, left main interventions, CTO PCI, and bypass graft interventions were performed in 1679 (15.2%), 236 (2.1%), 946 (8.5%), and 764 (6.9%) patients, respectively. The preferred access site was the femoral artery (n = 6614, 60%), and drug-eluting stents were deployed in 9230 (83.8%) patients. In-hospital mortality in the total registry data was reported in 104 (0.9%) patients. Conclusions: This report introduces the RHC-PCI Registry, its primary objectives, infrastructure, and preliminary results (the 3-year outcome).","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"9 1","pages":"47 - 51"},"PeriodicalIF":0.3,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41555235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heart Assessment and Monitoring in Rajaie Hospital (HAMRAH): A population-based cohort study Rajaie医院的心脏评估和监测:一项基于人群的队列研究
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2020-04-01 DOI: 10.4103/rcm.rcm_17_20
H. Bakhshandeh, M. Maleki, F. Noohi, S. Boudagh, Yasaman Khalili, A. Alizadehasl, N. Naderi, B. Mohebbi, Yousef Moghaddam, M. Haghjoo, M. Arabian, M. Alemzadeh-Ansari, M. Baay, H. Pouraliakbar, Zahra Ghaemmaghami, Shiva Khaleghparast, B. Ghadrdoost, H. Pasha, Zahra Hosseini, Reza Golpira, N. Mahdieh, Akbar Nikpajouh, Parham Sadeghipour
Background and Objectives: Cardiovascular diseases (CVDs) impose great burden on the health systems worldwide. The prevention of CVDs depends on the correct information about the perveance/incidence of them and their determinants in the community and population-based studies are the most accurate ways for obtaining these data. The objective of this study is to determine the prevalence of the classic risk factors of CVDs among healthy adult residents of Tehran and their changes through a 10-year follow-up in Tehran, the capital of Iran. This article presents the study protocol. Methods: Heart Assessment and Monitoring in RAjaie Hospital, is a population-based study conducted in Rajaie Cardiovascular Medical and Research Center, the largest tertiary care hospital for CVDs in Tehran. It consists two phases: A survey and a prospective cohort. People between 30 and 75 years of age, without known CVDs, invite through a multistage random sampling process. They will assess for the CVD risk factors, laboratory indices, electrocardiography and echocardiography features, diet, physical activity levels, psychological aspects, and peripheral vascular diseases. All the participants will be followed for 10 years and the changes in the above-mentioned factors and incidence of CVDs assessed. Discussion: It is expected that through obtaining valid, population-specific data, the information for policy making and efficient management of CVDs in Iranian people be provided.
背景和目的:心血管疾病给世界各地的卫生系统带来了巨大的负担。CVD的预防取决于社区中关于其变态反应/发病率及其决定因素的正确信息,基于人群的研究是获得这些数据的最准确方法。本研究的目的是通过在伊朗首都德黑兰进行为期10年的随访,确定德黑兰健康成年居民中心血管疾病经典风险因素的患病率及其变化。本文介绍了研究方案。方法:拉杰医院的心脏评估和监测是一项基于人群的研究,在德黑兰最大的心血管病三级护理医院拉杰心血管医学研究中心进行。它包括两个阶段:调查和前瞻性队列。年龄在30至75岁之间,没有已知心血管疾病的人,通过多阶段随机抽样过程进行邀请。他们将评估心血管疾病的危险因素、实验室指标、心电图和超声心动图特征、饮食、体力活动水平、心理方面和外周血管疾病。所有参与者将接受为期10年的随访,并评估上述因素的变化和心血管疾病的发生率。讨论:希望通过获得有效的、针对特定人群的数据,为伊朗人CVD的政策制定和有效管理提供信息。
{"title":"Heart Assessment and Monitoring in Rajaie Hospital (HAMRAH): A population-based cohort study","authors":"H. Bakhshandeh, M. Maleki, F. Noohi, S. Boudagh, Yasaman Khalili, A. Alizadehasl, N. Naderi, B. Mohebbi, Yousef Moghaddam, M. Haghjoo, M. Arabian, M. Alemzadeh-Ansari, M. Baay, H. Pouraliakbar, Zahra Ghaemmaghami, Shiva Khaleghparast, B. Ghadrdoost, H. Pasha, Zahra Hosseini, Reza Golpira, N. Mahdieh, Akbar Nikpajouh, Parham Sadeghipour","doi":"10.4103/rcm.rcm_17_20","DOIUrl":"https://doi.org/10.4103/rcm.rcm_17_20","url":null,"abstract":"Background and Objectives: Cardiovascular diseases (CVDs) impose great burden on the health systems worldwide. The prevention of CVDs depends on the correct information about the perveance/incidence of them and their determinants in the community and population-based studies are the most accurate ways for obtaining these data. The objective of this study is to determine the prevalence of the classic risk factors of CVDs among healthy adult residents of Tehran and their changes through a 10-year follow-up in Tehran, the capital of Iran. This article presents the study protocol. Methods: Heart Assessment and Monitoring in RAjaie Hospital, is a population-based study conducted in Rajaie Cardiovascular Medical and Research Center, the largest tertiary care hospital for CVDs in Tehran. It consists two phases: A survey and a prospective cohort. People between 30 and 75 years of age, without known CVDs, invite through a multistage random sampling process. They will assess for the CVD risk factors, laboratory indices, electrocardiography and echocardiography features, diet, physical activity levels, psychological aspects, and peripheral vascular diseases. All the participants will be followed for 10 years and the changes in the above-mentioned factors and incidence of CVDs assessed. Discussion: It is expected that through obtaining valid, population-specific data, the information for policy making and efficient management of CVDs in Iranian people be provided.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"9 1","pages":"29 - 34"},"PeriodicalIF":0.3,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44376931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Evaluation of the reliability and validity of the Iranian caregiver burden questionnaire for heart failure 伊朗照护者心力衰竭负担问卷的信度和效度评估
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2020-04-01 DOI: 10.4103/rcm.rcm_13_20
Marjohn Hamediseresht, Yasaman Khalili, Raana Asghari, S. Taghavi, A. Amin, N. Naderi
Introduction: It is important to have a strong appropriate tool for measuring, evaluating, and understanding the nature and consequences of chronic stresses on caregivers of patients with heart failure (HF). The purpose of this study is the assessment of the validity and reliability of the questionnaire for evaluating the burden on caregivers of patients with HF. Methods: In order to assess the burden of caregivers of patients with HF, the Caregiver Burden Questionnaire for Heart Failure version 3 (CBQ-HF, version 3) was used. After translation and back translation, the questionnaire was provided to 20 caregivers, and after 2 weeks, the same caregivers refilled the questionnaire; so that, we could measure its reliability by calculating Cronbach's alpha. Face validity and content validity were also obtained at this stage. Finally, the questionnaire was provided to eighty caregivers; hence, the total number of one hundred caregivers completed the questionnaire. Results: From a total of 100 collected questionnaires, 68 of participants were male and 32 of participants were female. The mean ± standard deviation of emotional burden on the patient's caregivers was 46 ± 10 and the median of the physical, social, and living pattern burden was 14, 4, and 13, respectively. The test–retest reliability showed high internal consistency (Cronbach's alpha: 94%). Conclusion: This study approved the Persian version of CBQHF questionnaire as a standard and valid tool in Persian language, which can be used among caregivers of patients with HF in order to examine their problems and to plan for improving their quality of life.
引言:重要的是要有一个强大的适当工具来测量、评估和理解慢性压力对心力衰竭患者护理人员的性质和后果。本研究的目的是评估评估HF患者护理人员负担的问卷的有效性和可靠性。方法:为了评估HF患者的护理人员负担,使用心力衰竭护理人员负担问卷第3版(CBQ-HF,第3版)。翻译和回译后,将问卷提供给20名护理人员,2周后,相同的护理人员重新填写问卷;因此,我们可以通过计算Cronbachα来衡量它的可靠性。这一阶段还获得了面孔有效性和内容有效性。最后,向80名护理人员提供了调查表;因此,共有100名护理人员完成了问卷调查。结果:在总共收集的100份问卷中,68名参与者是男性,32名参与者是女性。患者照顾者的情绪负担的平均值±标准差为46±10,身体、社会和生活模式负担的中位数分别为14、4和13。测试-再测试的可靠性显示出高度的内部一致性(Cronbachα:94%)。结论:本研究认可CBQHF问卷的波斯语版本是一种标准有效的波斯语工具,可在HF患者的护理人员中使用,以检查他们的问题并计划改善他们的生活质量。
{"title":"Evaluation of the reliability and validity of the Iranian caregiver burden questionnaire for heart failure","authors":"Marjohn Hamediseresht, Yasaman Khalili, Raana Asghari, S. Taghavi, A. Amin, N. Naderi","doi":"10.4103/rcm.rcm_13_20","DOIUrl":"https://doi.org/10.4103/rcm.rcm_13_20","url":null,"abstract":"Introduction: It is important to have a strong appropriate tool for measuring, evaluating, and understanding the nature and consequences of chronic stresses on caregivers of patients with heart failure (HF). The purpose of this study is the assessment of the validity and reliability of the questionnaire for evaluating the burden on caregivers of patients with HF. Methods: In order to assess the burden of caregivers of patients with HF, the Caregiver Burden Questionnaire for Heart Failure version 3 (CBQ-HF, version 3) was used. After translation and back translation, the questionnaire was provided to 20 caregivers, and after 2 weeks, the same caregivers refilled the questionnaire; so that, we could measure its reliability by calculating Cronbach's alpha. Face validity and content validity were also obtained at this stage. Finally, the questionnaire was provided to eighty caregivers; hence, the total number of one hundred caregivers completed the questionnaire. Results: From a total of 100 collected questionnaires, 68 of participants were male and 32 of participants were female. The mean ± standard deviation of emotional burden on the patient's caregivers was 46 ± 10 and the median of the physical, social, and living pattern burden was 14, 4, and 13, respectively. The test–retest reliability showed high internal consistency (Cronbach's alpha: 94%). Conclusion: This study approved the Persian version of CBQHF questionnaire as a standard and valid tool in Persian language, which can be used among caregivers of patients with HF in order to examine their problems and to plan for improving their quality of life.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"9 1","pages":"35 - 41"},"PeriodicalIF":0.3,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48397010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and angiographic profile of premature heart attack in patients with family history of premature coronary heart disease: A substudy of the PCAD registry (Registered under the Clinical Trials Registry of India [CTRI/2018/03/012544]) 有早发性冠心病家族史患者的临床和血管造影特征:PCAD注册的亚研究(注册于印度临床试验注册中心[CTRI/2018/03/012544])
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2020-04-01 DOI: 10.4103/rcm.rcm_15_20
Rahul Krishnarao Patil, C. Satvic, L. Shetty, H. N. Natraj Setty, Spandana Komma, Anesh Jain, T. Raghu, C. Manjunath
Aim: The aim is to study the clinical, social, biochemical, and angiographic profile of youth (under 35 years) with familial premature coronary artery disease (PCAD). Subjects and Methods: The PCAD registry is a prospective ongoing descriptive observational study of Indians aged below 40 years with coronary artery disease (CAD) which was started on April 1, 2017. Of 3450 patients registered in the PCAD registry till date, 1628 patients were aged 35 years or younger. Of these 1628 patients, 218 satisfied entry criteria. The entire clinical and angiographic profile of these patients was documented. The distribution of different lipid profile parameters was visualized by nonparametric density plot. The data were analyzed by statistical software R version 3.5.0. Results: Of 3450 patients registered in the PCAD registry till date, 1628 patients were aged ≤ 35 years. Two hundred and eighteen out of these 1628 patients (13.39%) belonged to the study group for this particular study. The mean age of all patients under the PCAD registry was 30.44 years, and 201 (92.2%) were males. 106 (48.62%) were smokers. Twenty-nine patients (13.33%) of them were diabetic. The most common index presentation of CAD in familial PCAD was with ST-elevation myocardial infarction (STEMI; 112 patients – 51.37%) and unstable angina/non-STEMI (58 patients – 26.6%). Forty-eight patients (22.01%) presented with evolved MI. Conclusions: Almost 14% of coronary events in younger age (under 35 years) were attributable to family history of CAD. Family history of CAD can be used as a criterion to select younger age population to perform targeted screening for cardiovascular diseases.
目的:目的是研究35岁以下青年家族性早发性冠状动脉疾病(PCAD)的临床、社会、生化和血管造影特征。受试者和方法:PCAD登记是一项前瞻性描述性观察性研究,于2017年4月1日开始,研究对象为年龄在40岁以下的印度冠状动脉疾病(CAD)患者。迄今为止在PCAD登记处登记的3450名患者中,有1628名患者年龄在35岁或以下。在这1628例患者中,218例符合入组标准。记录了这些患者的全部临床和血管造影资料。用非参数密度图显示不同血脂参数的分布。采用统计软件R 3.5.0对数据进行分析。结果:截至目前,在PCAD登记的3450例患者中,1628例患者年龄≤35岁。1628例患者中有218例(13.39%)属于本研究的研究组。PCAD登记的所有患者的平均年龄为30.44岁,201例(92.2%)为男性。106例(48.62%)为吸烟者。其中糖尿病29例(13.33%)。家族性PCAD最常见的指标表现为st段抬高型心肌梗死(STEMI;112例(51.37%)和不稳定性心绞痛/非stemi(58例- 26.6%)。48例患者(22.01%)表现为演变性心肌梗死。结论:近14%的年轻(35岁以下)冠状动脉事件可归因于CAD家族史。CAD家族史可作为选择低龄人群进行心血管疾病针对性筛查的标准。
{"title":"Clinical and angiographic profile of premature heart attack in patients with family history of premature coronary heart disease: A substudy of the PCAD registry (Registered under the Clinical Trials Registry of India [CTRI/2018/03/012544])","authors":"Rahul Krishnarao Patil, C. Satvic, L. Shetty, H. N. Natraj Setty, Spandana Komma, Anesh Jain, T. Raghu, C. Manjunath","doi":"10.4103/rcm.rcm_15_20","DOIUrl":"https://doi.org/10.4103/rcm.rcm_15_20","url":null,"abstract":"Aim: The aim is to study the clinical, social, biochemical, and angiographic profile of youth (under 35 years) with familial premature coronary artery disease (PCAD). Subjects and Methods: The PCAD registry is a prospective ongoing descriptive observational study of Indians aged below 40 years with coronary artery disease (CAD) which was started on April 1, 2017. Of 3450 patients registered in the PCAD registry till date, 1628 patients were aged 35 years or younger. Of these 1628 patients, 218 satisfied entry criteria. The entire clinical and angiographic profile of these patients was documented. The distribution of different lipid profile parameters was visualized by nonparametric density plot. The data were analyzed by statistical software R version 3.5.0. Results: Of 3450 patients registered in the PCAD registry till date, 1628 patients were aged ≤ 35 years. Two hundred and eighteen out of these 1628 patients (13.39%) belonged to the study group for this particular study. The mean age of all patients under the PCAD registry was 30.44 years, and 201 (92.2%) were males. 106 (48.62%) were smokers. Twenty-nine patients (13.33%) of them were diabetic. The most common index presentation of CAD in familial PCAD was with ST-elevation myocardial infarction (STEMI; 112 patients – 51.37%) and unstable angina/non-STEMI (58 patients – 26.6%). Forty-eight patients (22.01%) presented with evolved MI. Conclusions: Almost 14% of coronary events in younger age (under 35 years) were attributable to family history of CAD. Family history of CAD can be used as a criterion to select younger age population to perform targeted screening for cardiovascular diseases.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"9 1","pages":"42 - 46"},"PeriodicalIF":0.3,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44215574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Research in Cardiovascular Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1